REGN Latest Headlines

RBC Capital Sticks to Its Hold Rating for Regeneron (REGN)

at www.tipranks.com (Tue, 9-Dec 6:57 AM)

Kymera jumps on early-stage data for eczema candidate KT-621

at seekingalpha.com (Mon, 8-Dec 12:29 PM)

Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, and Bristol Myers in focus

at seekingalpha.com (Sun, 7-Dec 9:05 AM)

Notable analyst calls this week: Novartis, Albemarle and Zscaler among top picks

at seekingalpha.com (Sat, 6-Dec 10:35 AM)

Regeneron Q3 2025: Pipeline Wins, Dupixent Strength, and R&D Investments Define Performance

Market Chameleon (Tue, 28-Oct 7:14 AM)

Regeneron’s DB-OTO Gene Therapy Shows Dramatic, Sustained Hearing Restoration in Children: 11 of 12 Patients See Clinically Meaningful Gains

Market Chameleon (Mon, 13-Oct 7:33 AM)

FDA Expands Evkeeza’s Reach: Regeneron Wins Approval for Treating Ultra-Rare Childhood Cholesterol Disorder in Toddlers

Market Chameleon (Fri, 26-Sep 9:24 AM)